SCHEMBL23818008

SCHEMBL23818008

Cc1ccc(N(CCC#N)C(=O)CCl)cc1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 1.00
RAB9A P51151 5/20 1.00
NPC1 O15118 4/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
LMNA P02545 1/20 1.00
HTT P42858 3/20 0.64
FNIP1 Q8TF40 1/20 0.62
FEM1B Q9UK73 1/20 0.62
ATM Q13315 1/20 0.44
PAX8 Q06710 3/20 0.43
TP53 P04637 1/20 0.43
GPX4 P36969 1/20 0.43
GAA P10253 3/20 0.42
RECQL P46063 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31562917 1.00 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL23818012 0.89 ALDH1A1 (0.81) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL25455158 0.87 ALDH1A1 (0.78) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL23817999 0.85 ALDH1A1 (0.74) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL23818011 0.81 ALDH1A1 (0.68) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL25455169 0.78 ALDH1A1 (0.64) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL23818002 0.78 ALDH1A1 (0.64) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL23818000 0.78 ALDH1A1 (0.72) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL23818006 0.78 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL23818001 0.77 ALDH1A1 (0.62) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-11 US disclosed
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-11 US disclosed
WO-2021183431-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF FEM1B, GSKIP, FNIP1 ALDH1A1 4563/4885RAB9A 1865/4885NPC1 3656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.